Literature DB >> 6482934

Right-sided infective endocarditis as a consequence of flow-directed pulmonary-artery catheterization. A clinicopathological study of 55 autopsied patients.

K M Rowley, K S Clubb, G J Smith, H S Cabin.   

Abstract

We studied 142 consecutively autopsied patients prospectively to determine the frequency and clinical importance of right-sided endocardial lesions in patients who had undergone flow-directed pulmonary-artery catheterization within one month of death. Of the 55 catheterized patients, 29 (53 per cent) had one or more right-sided endocardial lesions: 12 (22 per cent) had subendocardial hemorrhage, 11 (20 per cent) sterile thrombus, 2 (4 per cent) hemorrhage and thrombus, and 4 (7 per cent) infective endocarditis. Of 41 lesions seen in the 29 patients, 23 (56 per cent) were located on the pulmonic valve, 6 (15 per cent) on the tricuspid valve, 6 (15 per cent) in the right atrium, 4 (10 per cent) in the right ventricle, and 2 (5 per cent) in the main pulmonary artery. All four patients with infective endocarditis had had positive antemortem blood cultures while the catheter was in place, but in only one had the diagnosis of endocarditis been suspected clinically. The unusual locations of the infected vegetations (on the pulmonic valve in three and in the right atrium in one) and the similar location of the uninfected lesions suggest that the infective endocarditis was a consequence of catheter-induced endocardial damage with concurrent or subsequent bacteremia. Among the 87 non-catheterized patients, there were two subendocardial hemorrhages and one resolving right atrial thrombus. We conclude that endocardial damage from flow-directed pulmonary-artery catheterization is common and that right-sided infective endocarditis should be suspected in bacteremic catheterized patients.

Entities:  

Mesh:

Year:  1984        PMID: 6482934     DOI: 10.1056/NEJM198411013111804

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  22 in total

Review 1.  European Society of Intensive Care Medicine. Expert panel: the use of the pulmonary artery catheter.

Authors: 
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

2.  Because It's There.

Authors:  T Dixon
Journal:  Can Fam Physician       Date:  1987-11       Impact factor: 3.275

3.  Inadvertant atrial fixation of a Swan-Ganz catheter by suture and a method for its percutaneous removal.

Authors:  M H Wholey; E A Zikria; B Boyle
Journal:  Cardiovasc Intervent Radiol       Date:  1987       Impact factor: 2.740

4.  Disseminated zygomycosis and systemic lupus erythematosus.

Authors:  C A Bloxham; S Carr; D W Ryan; P J Kesteven; R S Bexton; I D Griffiths; J Richards
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

5.  Effects of interleukin-1, lipopolysaccharide, and streptococci on procoagulant activity of cultured human cardiac valve endothelial and stromal cells.

Authors:  T A Drake; M Pang
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

6.  Measurement of right atrial oxygen saturation by fiberoptic oximetry accurately reflects mixed venous oxygen saturation in swine.

Authors:  G G Davies; J Mendenhall; T Symreng
Journal:  J Clin Monit       Date:  1988-04

7.  Isolated native tricuspid valve endocarditis caused by viridans streptococcus.

Authors:  J Swiston; S D Shafran; N Kassam
Journal:  Can J Infect Dis       Date:  2001-09

8.  Swan-Ganz catheter-related pulmonary valve infective endocarditis: a case report.

Authors:  G Bernardin; D Milhaud; P M Roger; G Pouliquen; P Corcelle; M Mattei
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

9.  Preoperative optimization of cardiovascular hemodynamics improves outcome in peripheral vascular surgery. A prospective, randomized clinical trial.

Authors:  J F Berlauk; J H Abrams; I J Gilmour; S R O'Connor; D R Knighton; F B Cerra
Journal:  Ann Surg       Date:  1991-09       Impact factor: 12.969

10.  Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin).

Authors:  D K Jones; T W Higenbottam; J Wallwork
Journal:  Br Heart J       Date:  1987-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.